First and Only CD19-Targeted Therapy Approved in Europe for Adults with anti-AChR+ and anti-MuSK+ gMGUPLIZNA Demonstrates Durable Disease Control with Twice-Yearly Dosing*THOUSAND OAKS, Calif.
Hosted on MSN
5 warning signs you could have an autoimmune disease
Here is a list of some of these symptoms; remember, if you have any health concerns, be sure to contact a healthcare professional. Scrap 'unfair' migrant crackdown, Labour MPs tell Starmer The Epstein ...
Northwestern Medicine scientists in the laboratory of Stephen Miller, Ph.D., professor emeritus of Microbiology–Immunology, have identified the cellular and molecular mechanisms required for the ...
Bacteria in the human gut can directly deliver proteins into human cells, actively shaping immune responses. A consortium led by researchers at Helmholtz Munich, with participation from Ludwig ...
Dr. Veena Joy, the US Autoimmunity Lead for Medical and Scientific Affairs at Thermo Fisher Scientific discusses her career transition from academic research to industry work at Thermo Fisher ...
A major winter storm is spreading heavy snow and damaging ice across a large portion of the United States. Extremely cold temperatures will only worsen the storm and increase its danger. The storm’s ...
Please provide your email address to receive an email when new articles are posted on . Epstein-Barr virus activates certain B cells involved in systemic lupus erythematosus disease pathogenesis. The ...
BUENOS AIRES, Dec. 4 (UPI) --Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage. The finding opens the door to new ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Scientists looked at the effect of ultraviolet radiation on human and mouse ...
Nerandomilast, a PDE4B inhibitor, is a new treatment option for IPF, showing better tolerability than nintedanib and pirfenidone. The FIBRONEER trials support nerandomilast's efficacy in reducing ...
GOSSELIES, Belgium and NANTES, France, Nov. 12, 2025 /PRNewswire/ -- AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from ...
New possibilities for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID are emerging as research continues to untangle the complex, multisystem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results